Across TCGA pan-cancer cohorts, LINC01392 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of LINC01392’s most consistent transcriptional readouts.
The strongest signal is observed in bladder urothelial carcinoma (BLCA), where LINC01392 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01392 is over-expressed in tumor.
BLCA are the cancer types where LINC01392 tumor–normal differential expression is most reproducible.